Altria Q2 Profit Falls as Smokers Flee to Discount Brands; Stock Drops 7%
MO sits 27% above its 52-week low of $54.7.
Summary
Altria's Q2 adjusted EPS of $1.48 missed consensus by two cents, but the real story is a sharp consumer trade-down: discount cigarette sales surged 67% while premium Marlboro volumes fell single digits. Oral-tobacco revenue dropped 5.3% on an 8.5% shipment decline, losing retail share in the high-growth nicotine pouch category. Total revenue of $6.11 billion beat estimates, but the mix shift toward lower-margin products pressured profit. Shares fell 7%, accelerating from the initial 3.4% drop on the earlier headline. Full-year guidance was narrowed to $5.61–$5.72, with management citing expected H2 benefits from cigarette import/export activity. This follows the earlier Q2 release and plant consolidation announcement, adding granular detail on the deteriorating premium mix and competitive pressures from Philip Morris's Zyn.
At the time of this announcement, MO was trading at $69.33 on NYSE in the Trade & Services sector, with a market capitalization of approximately $115.8B. The 52-week trading range was $54.70 to $77.06. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.